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Abstract
K-Ras dependent non-small cell lung cancer (NSCLC) cells are ‘addicted’ to basal autophagy that reprograms cellular
metabolism in a lysosomal-sensitive manner. Here we demonstrate that the xenophagy-associated kinase TBK1 drives basal
autophagy, consistent with its known requirement in K-Ras-dependent NSCLC proliferation. Furthermore, basal autophagy
in this context is characterised by sequestration of the xenophagy cargo receptor Ndp52 and its paralogue Tax1bp1, which
we demonstrate here to be a bona fide cargo receptor. Autophagy of these cargo receptors promotes non-canonical NF-kB
signalling. We propose that this TBK1-dependent mechanism for NF-kB signalling contributes to autophagy addiction in K-
Ras driven NSCLC.
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Introduction
A strategy to target tumour progression is to identify specific
molecular vulnerabilities conferred by genetic background. Acti-
vation of K-Ras by mutation, or other means, renders non-small
cell lung cancer (NSCLC) cells ‘addicted’ to the presence of TBK1
(TANK-binding kinase 1) protein for continued proliferation and/
or survival [1], possibly via direct stimulation of TBK1 activity [2].
TBK1 and its paralogue, IKKe, alongside the well-characterised
IKKa and IKKb proteins, constitute a subfamily of serine-
threonine protein kinases [3]. TBK1 and IKKe were originally
described as mediating NF-kB transcription factor activation
[4,5,6]. It has also been proposed that constitutive promotion of
NF-kB signalling in NSCLC cells, downstream of K-Ras, could
underlie TBK1 ‘addiction’ [1]. Indeed, gene expression profiling
has shown that a K-Ras driven, NF-kB-like signature is dependent
upon the TBK1 gene [1]. However, mechanistic evidence for
TBK1-mediated NF-kB engagement in cancer has been sparse.
Alternative explanations of TBK1 addiction have been proposed,
such as direct activation of pro-survival Akt kinase signalling [7,8].
However, no individual contribution of TBK1 is necessarily
mutually exclusive with others.
A second pathway engaged downstream of K-Ras activation is
macroautophagy (hereafter autophagy) [9,10,11]. Autophagy is
a multistep lysosomal degradation process [12]. In the early stages,
dependent upon the action of core autophagy genes such as ATG5
and ULK1, double membraned vesicles decorated with ubiquitin-
like proteins of the LC3/GABARAP family, called autophago-
somes, begin to form. These nascent autophagosomes enclose
around, and sequester, cytosol as they mature. Depending upon
context, this can be a non-selective or selective process, the latter
involving sequestration of discrete populations, or ‘cargoes’, of
organelles, proteins or other structures, such as bacteria in the case
of ‘xenophagy’. Selectivity is mediated via cargo receptors that link
LC3/GABARAP proteins to the cargo, in presumed multi-
molecular complexes [12]. Autophagy impacts on cell fate by
both this selective sequestration of cargo complexes from the
cytosol and via subsequent lysosomal degradation of the contents
of autophagosome, which releases metabolites into the cytosol.
This latter step is inhibited by lysosomotrophic drugs such as
chloroquine. Such compounds are a potential class of agents for
therapeutic manipulation of autophagy [11,13].
The role of autophagy in acute response to Ras mutation is
unclear. It has been demonstrated to act as an effector of survival,
cell death or senescence [9,14,15]. However, continuous basal
autophagy is unambiguously required for the proliferation and/or
survival of established K-Ras driven cancer cells [10,11,13]. A role
of autophagy here is direct regulation of cellular metabolism, via
mitochondrial homoeostasis, protein quality control and/or
remodelling of the cellular metabolite pool. Cumulatively, these
mechanisms regulate the balance between oxidative phosphoryla-
tion and aerobic glycolysis [10,11,13]. Some of these mechanisms
are dependent upon lysosomal degradation, as shown by sensitivity
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of metabolic effects to lysosomotrophic agents such as chloroquine.
However, it has not been addressed how autophagy is engaged
downstream of K-Ras. Additionally, it is not clear whether
autophagy ‘addiction’ can be explained solely by direct metabolic
effects or if sequestration of specific proteins modulates cell fate,
via alteration of signal transduction within the cell.
Interestingly, TBK1 has been implicated in the autophagy of
cytosolic Salmonella spp. bacteria from within cells [16]. The novel
TBK1-binding protein and xenophagy cargo receptor, Ndp52,
recognises ubiquitinated proteins, on the surface of bacteria, and
carbohydrate-binding proteins on ruptured host vesicles [17,18]. A
non-redundant step in this pathway has recently been demon-
strated to be the TBK1-mediated phosphorylation of a further
novel cargo receptor, Optineurin [16]. The relevance of TBK1
signalling outside of xenophagy is unclear. However, we show here
that basal autophagy, with some parallels to xenophagy and
resulting in turnover of cargo receptors such as Ndp52 and the
paralogous protein Tax1bp1, is constitutively engaged in TBK1-
addicted NSCLC cells by the kinase activity of TBK1. We
demonstrate a central role for this autophagy in driving non-
canonical NF-kB signalling mediated via the RelB transcription
factor. We propose that this pathway complements direct
metabolic mechanisms in the contribution of basal autophagy to
supporting proliferation and/or survival in NSCLC cells. Our
findings thus expand the role of autophagy addiction in K-Ras
driven cancer and show mechanistic interplay with the TBK1-NF-
kB pathway.
Results
Autophagy in K-Ras Dependent Lung Cancer Cells is
Downstream of TBK1 Kinase
To investigate the role of TBK1 in K-Ras driven basal
autophagy we developed a NSCLC culture model in K-Ras
‘addicted’ A549 cells [1]. We found that the cytosol of these
contained abundant punctate structures that labelled with GFP-
LC3B fusion protein, but not with lipid-unconjugatable GFP-
LC3BDG-.A (Fig. 1a). The abundance of GFP-LC3B puncta was
dramatically elevated by chloroquine treatment (Fig. 1a). Accord-
ing to the methodology of the field [19], we then took these LC3B
puncta to represent a basal, steady-state level of autophagosomes.
These autophagosomes were absent when RNAi was used to
knockdown the autophagy genes ATG5 and ULK1 (Fig. 1b-d).
RNAi of TBK1 produced similar effects, positioning this kinase
upstream of basal autophagosome abundance (Fig. 1b-d). We
extended these findings using autophagy flux assays in combina-
tion with a member of a recently described family of enzymatic
inhibitors of TBK1 (MRT68601, hereafter referred to as TBKi,
Fig. S1) [20]. Inhibitor treatment of A549 tandem-fluorescent
LC3B cells [21] resulted in reduction of both early autophagic
(‘green+red‘) LC3B puncta and acidic late autophagosomes (‘red’
puncta) (Fig. 1e, f). Correspondingly, chloroquine-mediated
accumulation of lipidated LC3B-II or GABARAP-II, the form of
these proteins correlated with formation of autophagosomes, was
prevented by inhibitor treatment (Fig. 1g). Taken together, these
data show that TBK1 kinase indeed promotes autophagy, acting
at the early step of autophagosome formation, rather than
repressing autophagosome maturation into the lysosomal acidic
compartment [19].
Basal Autophagy Targets the Cargo Receptors Ndp52
and Tax1bp1
Bacterial autophagy (xenophagy) is mediated via TBK1 and its
binding partners, the xenophagy cargo receptors Ndp52 and
Optineurin [16,18]. In a parallel to this, we found recruitment of
Ndp52, and the Ndp52 paralogue Tax1bp1, to basal autophago-
somes in A549 cells (Fig. 2a, c). We also demonstrated
a constitutive Ndp52-TBK1 complex and confirmed a previous
report that Tax1bp1 could bind TBK1 [22] (Fig. S2a, b). These
data imply that Ndp52 and Tax1bp1 may be being targeted for
sequestration by basal autophagy. Accordingly, chloroquine
treatment stabilised Tax1bp1 similar to a positive control, the
p62 cargo receptor (Fig. 2b), and concomitant with increased
Tax1bp1 localisation to LC3B-positive vesicles (Fig. 2c). Ubiqui-
tin-like proteins of the LC3 and GABARAP subfamilies are
capable of binding Tax1bp1, with varying affinities (Fig. 2d). This
suggests that Tax1bp1 is, like, Ndp52, a bona fide cargo receptor
protein. Further support for this finding comes from the
observation that deletion of putative LC3/GABARAP family
binding motifs in Tax1bp1 ablates localisation to autophagosomes
(Fig. 2e). These motifs include both an ‘canonical’ LIR (LC3-
interacting region) motif (W49, V50, G51, I52) and a ‘non-
canonical LIR’ motif, the latter inferred from that recently
described for Ndp52 binding to LC3C (L141, V142, V143) [23]
(Fig. 2e, also see alignments in Fig. S2c). Consistent with the role of
TBK1 in the above processes, TBK1 protein was also shown to
localise to basal autophagosomes (Fig. 2f).
TBK1 Drives Non-canonical NF-kB Signalling by
Autophagic Sequestration of Ndp52 and Tax1bp1
We next hypothesised a link between TBK1-driven autophagy
and basal NF-kB signalling. Nuclear localisation of canonical NF-
kB pathway subunits c-Rel or RelA was not detectable in the A549
cell line (p53 wild-type), but basal nuclear localisation of the non-
canonical pathway subunit RelB was detectable (Fig. S3). RelB
nuclear localisation was dependent upon TBK1 kinase activity as
shown by the loss of nuclear RelB stain (Fig. 3a, b) or loss of
residency in the nuclear fraction (Fig. 3c) upon treatment with
TBK1 inhibitor. Tax1bp1 has previously been demonstrated to
inhibit canonical NF-kB signalling by nucleation of an ubiquitin
editing complex for canonical NF-kB regulators TRAF6 and RIP1
[24]. However, conflicting reports have demonstrated an NF-kB
potentiating effect, albeit downstream of the dysregulation of
Tax1bp1 function by the viral oncoprotein Tax [25]. We found
that RNAi of ATG5, ULK1, TBK1, TAX1BP1 or NDP52 inhibited
RelB nuclear localisation (Fig. 3d-f), implying that a downstream
consequence of Tax1bp1 and Ndp52 sequestration by autophagy
is engagement of non-canonical NF-kB. Treatment with the
autophagy inhibitory compound 3-MA (3-methyl adenine) also
ablated RelB nuclear localisation, further supporting these findings
(Fig. 3g). It is not clear whether autophagic degradation of cargo in
lysosomes, or mere autophagic sequestration of cargo, is required
for RelB signalling. While E64d/Pepstatin A treatment had no
inhibitory effect on RelB nuclear localisation, a small but
significant effect was seen with high doses of chloroquine and
a marked inhibitory effect was seen with Bafilomycin A1 (Fig. S4).
To confirm the observation that autophagy promotes RelB
activity, we assessed changes in gene transcription. Analyses of
potential RelB target genes demonstrated that BIRC3 mRNA
levels were robustly downregulated by RelB inhibition (Fig. 3 h, i).
Importantly, RNAi of ATG5, ULK1, TAX1BP1 and TBK1 similarly
downregulated BIRC3 mRNA (Fig. 3j).
RelB Activity Contributes to TBK1 and Autophagy
‘Addiction’
We confirmed previous observations [1,11] that chronic
silencing of ATG5 or TBK1, by lentiviral shRNA targeting, led
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Figure 1. TBK1 kinase activity engages basal autophagy in A549 NSCLC cells. a) A549 GFP-LC3B or GFP-LC3BDG-.A cells were treated
with PBS or 5 mM chloroquine (CQ) for 8 h and cells imaged for GFP. b, c) A549 GFP-LC3B cells were transfected with indicated siRNA for 72 h
(NTC=non-targeting control) and b) cell extracts blotted for indicated proteins (a-tub=a-tubulin) or cells were c) imaged for GFP-LC3B puncta. d)
A549 FLAG-HA-LC3B cells were transfected with indicated siRNA and HA-positive puncta immunostained, imaged and counted at 72 h (n = 3, 6
S.E.M., * = p,0.05, ** = p,0.01). e,f) A549 tandem-fluorescent-LC3B (tfLC3B) cells were treated with DMSO or 1 mM MRT68601 (TBKi) for 24 h and e)
imaged and f) quantified for total number of autophagic puncta (green+red) and the subset of these puncta with undetectable GFP signal (red), as
described in detail in Materials and Methods. g) A549 cells were treated with DMSO or 10 mM MRT68601 (TBKi) for 24 h in the presence or absence of
PBS or 5 mM (CQ) chloroquine and cell extracts blotted for indicated proteins. Scale bars = 50 mm in all panels.
doi:10.1371/journal.pone.0050672.g001
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Figure 2. Basal autophagy targets TBK1-binding proteins Ndp52 and Tax1bp1. a) A549 GFP-LC3B cells were stained for Ndp52 and
imaged. b,c) A549 cells were treated with PBS or 5 mM chloroquine (CQ) overnight and b) cell extracts blotted for indicated proteins (a-tub= alpha
tubulin) or c) cells co-stained for Tax1bp1 and LC3B, and imaged by confocal microscopy. d) 293FT cells were transfected with myc-TAX1BP1
expression vector, or empty vector control, and lysates subjected to pull-down with indicated fusion protein, as described in Materials and Methods
(- = GST only, B =GST-LC3B, C =GST-LC3C, G =GST-GABARAP). e) A549 FLAG-HA-TAX1BP1 cell lines stably expressing the indicated variants of
Tax1bp1 protein (see text) were treated with 5 mM chloroquine overnight and stained for HA puncta. f) A549 GFP-TBK1 mCherry-LC3C cells were
imaged (arrows indicate colocalisation). Scale bars = 25 mm in all panels.
doi:10.1371/journal.pone.0050672.g002
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to a decrease in cell number in A549 cells, as did RNAi of KRAS
(Fig. S5a-f). Importantly, lentiviral RNAi of RELB also led to
marked reduction in cell number (Fig. 3k). This suggests TBK1-
and autophagy-mediated regulation of RelB may, at least partly,
underlie TBK1- and autophagy-addiction.
Autophagy and Ndp52/Tax1bp1-mediated RelB
Signalling can be Independent of Optineurin and
Tax1bp1 does not Promote Canonical NF-kB Signalling
In A549 cells, the other autophagy cargo receptor previously
implicated in TBK1 function, Optineurin [16], appears to have
Figure 3. TBK1, autophagy and the Tax1bp1/Ndp52 cargo receptors maintain pro-survival/proliferation non-canonical NF-kB
signalling in A549 NSCLC cells. a–c) A549 cells were treated overnight with DMSO or 10 mM MRT68601 (TBKi) and a) stained for RelB (scale
bar = 50 mm), nuclear localisation quantified in b) (n = 3, 6 S.E.M., ** = p,0.01) or c) nuclear extracts prepared and blotted for indicated proteins. d–f)
A549 cells were transfected with indicated siRNA (NTC=non-targeting control) for 72 h and e) cell extracts blotted for indicated proteins or d,f) cells
were stained and quantified for nuclear RelB (n = 3, 6 S.E.M., * = p,0.05). g) A549 cells were treated with PBS or 10 mM 3-methyladenine (3-MA) for
24 hours and then stained and quantified for nuclear RelB (n = 3, 6 S.E.M., *** = p,0.005). h,i) A549 cells were infected with indicated lentivirus and,
at 72 h post infection, h) cell extracts blotted for indicated proteins or i) total RNA quantified for BIRC3 mRNA (n = 3; 6 S.D.). j) A549 cells were
transfected with indicated siRNA for 72 h and total RNA extracts were subjected to qRT-PCR for BIRC3 mRNA (n= 3; 6 S.D.). k) A549 cells were
infected with indicated lentivirus and at 120 h post infection cell number counted as described in Materials and Methods (n = 3,6 S.E.M., * = p,0.05).
doi:10.1371/journal.pone.0050672.g003
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limited involvement in RelB signalling. There is only a small,
albeit significant, reduction in RelB nuclear localisation upon
OPTN RNAi (Fig. 4a, b). However, these findings do not exclude
a role for Optineurin in different genetic backgrounds or under
stress conditions, and these possibilities shall be addressed in future
work. In A549 cells, the role of Tax1bp1 in promoting NF-kB
signalling is also specific to the novel autophagy-RelB pathway
described herein. Stimulation of canonical NF-kB signalling by
TNFa treatment, as assessed by nuclear localisation of RelA, is not
perturbed by TAX1BP1 RNAi, at least insofar as no reduction of
TNFa-induced nuclear translocation is observed (Fig. 4c, d). Thus
the stimulatory role of Tax1bp1 on NF- kB appears to be specific
for non-canonical RelB signalling. However, it is important to note
that this assay does not address the already well-described
inhibitory role of Tax1bp1 on the duration and magnitude of
canonical NF- kB signalling [24].
RelB Activation by Autophagy and Ndp52/Tax1bp1 is
also seen in p53-mutated, K-Ras-dependent NSCLC Cells
It has been proposed that in p53-mutated NSCLC lines, such as
NCI-H23, basal canonical NF-kB signalling is much higher than
in p53 wild-type lines, such as A549. However, at least in NCI-
H23, we still find constitutive engagement of RelB signalling,
dependent upon basal autophagy function, suggesting that basal
non-canonical and canonical NF-kB signalling may be co-incident
(Fig. 5a-e). Specifically, we found that NCI-H23 cells had
constitutive autophagy, as assessed with tandem-fluorescent LC3
marker protein, which was downregulated by TBK1 RNAi (Fig. 5a-
c), and that constitutive nuclear localisation of RelB in this cell line
was sensitive to RNAi-mediated inhibition of TBK1, ATG5, NDP52
or TAX1BP1 (Fig. 5d, e).
A Model for Engagement of Basal RelB Signalling in K-
Ras-dependent Lung Cancer Cells
The data presented in this manuscript lead to the formulation of
the following model (Fig. 6). While the activity of TBK1-binding
cargo receptors Optineurin, Ndp52 and, potentially, Tax1bp1,
drives autophagy of bacterial cells during xenophagy, a similar
TBK1-mediated autophagic sequestration of Tax1bp1 and Ndp52
is driven by basal autophagy in K-Ras-dependent NSCLC cells.
This leads to engagement of non-canonical NF-kB signalling and
cell proliferation and/or survival. Whether TBK1 also regulates
the direct, lysosomal function of autophagy in cellular metabolism
is unknown; it also remains to be addressed whether this role of
autophagy is experimentally dissociable from selective sequestra-
tion of Tax1bp1 and Ndp52. Mechanistically, it is also not clear
how TBK1 drives autophagy. However, as this manuscript was in
the final stages of revision, the group of Deretic published that
phosphorylation of the general function autophagy receptor and
facilitator of autophagosome biogenesis, p62/SQSTM1, in the
Figure 4. Analysis of roles of Optineurin in RelB signalling and Tax1bp1 in RelA signalling in A549 NSCLC cells. a,b) A549 cells were
transfected with indicated siRNA (NTC=non-targeting control) for 72 h and a) cell extracts blotted for indicated proteins or b) cells stained and
quantified for nuclear RelB (n = 3, 6 S.E.M., * = p,0.05). c,d) A549 cells were transfected with indicated siRNA (NTC=non-targeting control) and
stimulated with 5 ng/ml TNF-a for 3 h and c) stained and d) quantified for nuclear RelA (n = 3, 6 S.E.M.). Scale bar = 25 mm.
doi:10.1371/journal.pone.0050672.g004
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ubiquitin-binding (UBA) domain, may be involved in a novel role
for TBK1 in starvation-induced autophagy [26,27]. Indeed, initial
results from this laboratory suggest that A549 cells have basally
phosphorylated p62 that is decreased in abundance by TBKi
treatment (Fig. S6).
Discussion
Autophagy is a multifaceted process, enacting changes in cell
fate by both non-selective and selective mechanisms [12]. It is
likely that the engagement of autophagy in cancer cells acts
directly on both metabolism [10,11,13] and cell signalling, in an
integrated response. It is tempting to speculate that xenophagy is
coupled to an innate immune signalling response via non-
canonical NF-kB, and this mechanism is simply aberrantly
engaged by oncogene-driven autophagy in NSCLC cells. The
role of TBK1 in driving autophagy may also explain how
autophagy is engaged, despite predicted high basal mTOR
activity, in NSCLC cells. Mechanistically, p62 phosphorylation
may play a role in this process [26]. However, we speculate that
TBK1 is a promiscuous kinase with numerous substrates, and
predict that p62, and indeed Optineurin (adjacent to LIR motif)
Figure 5. Basal autophagy drives nuclear RelB localisation in NCI-H23 NSCLC cells. a) NCI-H23 cells were transfected with indicated siRNA
(NTC=non-targeting control) for 72 h and a) cell extracts blotted for indicated proteins. b,c) NCI-H23 tandem-fluorescent LC3B cells were transfected
with indicated siRNA and analysed as described in Materials and Methods. d,e) NCI-H23 cells were transfected with indicated siRNA for 72 h and cells
were d) stained and e) quantified for nuclear RelB (n = 3, 6 S.E.M., * = p,0.05, ** = p,0.01). Scale bar = 50 mm in all panels.
doi:10.1371/journal.pone.0050672.g005
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phosphorylation [16], represent merely a subset of functionally
relevant targets of TBK1 in autophagy. It is thus possible that
different substrates of TBK1 act at different stages of autophagy,
either at early steps, as our data would suggest, or at later
maturation steps, as has been recently proposed [26].
Generally, NF-kB signalling has been thought to lie upstream of
autophagy [28,29,30]. However, direct regulation of canonical
NF-kB signalling by autophagy has recently been proposed.
Hypothesised mechanisms have included sequestration of p62,
IkBa, NEMO or Bcl10 [31,32,33,34,35]. The diversity of
mechanisms of autophagy action illustrates the diverse functions
of this process; here we add another mechanism of NF-kB
regulation, this time in regulation of the non-canonical RelB
pathway. Recently, aberrant RelB activity has been identified in
lung tumours, fitting with our model [36]. However, p53 wild-type
NSCLC might also be dependent, to some degree, upon canonical
NF-kB signalling [37,38]. Indeed, A549 cells (p53 wild-type) are
dependent upon c-Rel activity for proliferation and survival [1].
This is not mutually exclusive with our results; an undetectable
quantity of nuclear c-Rel could be necessary for proliferation/
survival, along with RelB. Indeed, the context of p53-mutated
NSCLC, where engagement of canonical NF-kB signalling is
much more evident [39], will be a good arena to dissect such
interplay. Interestingly, we have shown in this manuscript that in
at least some cell lines with p53 mutation, and reported prominent
basal canonical NF-kB signalling (e.g. NCI-H23), that basal,
autophagy-driven RelB nuclear localisation can be nonetheless
detected. Future investigation of the autophagy cargoes brought to
autophagosomal membranes by Tax1bp1 and Ndp52, ubiquiti-
nated or otherwise, will also shed light upon the mechanism by
which these cargo receptors are involved in the mediation of non-
canonical NF-kB signalling. Proteomic experiments to determine
the identity of these cargoes are underway in our laboratory.
Given the interest in developing TBK1 inhibitors for cancer
treatment, we need to understand in detail the consequences of
loss of the pathway described here. In the in vivo setting, the effects
of RelB regulation by autophagy and TBK1 are unlikely to be
wholly cell autonomous, given the well-established role of NF-kB
signalling in controlling cell-cell communication and inflamma-
tion. Interestingly, TAX1BP1 may regulate intestinal tumourigen-
esis in mouse models of cancer [40]. Also, germline TAX1BP1
knockout mice display an organ-specific inflammatory phenotype
[41]. It is possible that these observations may relate to the role for
Tax1bp1 described here or, alternatively, to the better described
role in repressing canonical NF-kB signalling [24]. Finally,
targeting of autophagy is also proposed as a means of cancer
treatment, at least in some genetic backgrounds. The data here
suggest caution in extrapolating the results of genetic inhibition of
autophagy by targeting autophagosome formation and sequestra-
tion, to the action of drugs that target lysosomal function, such as
chloroquine, protease inhibitors or bafilomycin A1. It is not clear
that agents such as these will effect all the changes, such as NF-kB
activity, that targeting the early stages of autophagy will, and vice-
versa.
Figure 6. Model of autophagy function in K-Ras addiction versus xenophagy. See text for detailed discussion. Ub= ubiquitin.
doi:10.1371/journal.pone.0050672.g006
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Materials and Methods
Cell Lines and Plasmids
All cells were cultured in DMEM (Sigma) +10% FCS (Sigma)
under 5% CO2 at 37uC. HEK293FT cells were from Invitrogen.
A549 cells used were obtained from Institute of Cancer Research
(London, UK) and identity verified by microsatellite genotyping
(Health Protection Agency, UK). NCI-H23 cells were purchased
directly from ATCC. A549 and NCI-H23 cells were derivatised to
express Ecotropic Receptor using pEcoR-neo and selection in
G418. Retrovirus to make stable infectants was generated in
Phoenix-Eco cells by standard techniques. These viruses were:
pBabe GFP-LC3B puro [42]: rat LC3B cDNA fused N-
terminally to GFP. pBabe GFP-LC3BDG-.A puro: above
plasmid encoding protein truncated so C-ter Gly exposed by
processing of C-terminus by Atg4 is constitutively exposed. This
C-ter Gly is mutated to Ala. pBabe tfLC3B puro: pBabe puro
with tandem fluorescent LC3B [21] cloned in NheI (blunt)/SalI
into SnaBI/SalI site. pWZL GFP-TBK1 HYGRO: pWZL GFP
DEST IRES HYGRO vector (unpublished) with full length TBK1
fused to C-terminus of GFP by recombination with pDONR 223
TBK1 (unpublished) by Gateway technology (Invitrogen). pBabe
mCherry LC3C BLAST: pBabe Cherry DEST BLAST vector
(unpublished) with full length LC3C fused to C-terminus of
mCherry by recombination with pDONR 223 LC3C [43] by
Gateway technology (Invitrogen). MSCV FLAG-HA-LC3B: As
described in literature {Behrends, 2010 #4}. MSCV FLAG-HA-
TAX1BP1 (WT and LIR mutants): TAX1BP1 cDNA was
cloned into pDONR 223 by standard Gateway cloning techniques
using pcDNA 3.1 myc-TAX1BP1 (below) as a template.
TAX1BP1 cDNA was then Gateway cloned into MSCV NTAP
IRES PURO [43]. Site-directed mutagenesis was performed in
pDONR prior to recombination into MSCV NTAP IRES PURO
to produce cDNA encoding TAX1BP1 with mutations in the
putative canonical or non-canonical LIR motif (mutations as
described in text). All mutagenized cDNAs were fully sequenced.
Other plasmids used in this study were: pcDNA 3.1 myc-His:
Invitrogen, pcDNA 3.1 myc-TAX1BP1: myc-TAX1BP1 full-
length cDNA (NCBI isoform 1) was PCR amplified with the
following primers from an IMAGE clone and cloned BamHI-
XhoI into pCDNA 3.1 myc-His: GGA TCC GCC ACC ATG
GAG CAG AAG CTG ATT TCC GAG GAG GAC CTG ACA
TCC TTT CAA GAA GTC CCA TTG CAG ACT TC and
CTC GAG CTA GTC AAA ATT TAG AAC ATT CTG ATC
AAA ATG GGT C. The resultant cDNA encodes the 307I variant
of this protein (common polymorphism). pDEST15-empty
vector (for expression of GST control protein): created by
inserting an in-frame stop codon containing cassette into
pDEST15 by Gateway cloning from a specially constructed
pDONR223 plasmid. pDEST15-LC3B, pDEST15-LC3C and
pDEST15-GABARAP (for expression of GST fusion proteins)
were created by recombination with pDONR 223 LC3B,
pDONR 223 LC3C or pDONR 223 GABARAP [43] by Gateway
technology (Invitrogen).
Chemicals
Chloroquine was obtained from Sigma and maintained as
a frozen stock solution in PBS. 3-MA was obtained from Sigma
and fresh solutions made in DMEM prior at working concentra-
tion prior to application to cells. TNFa was obtained from Sigma
and stored in frozen aliquots in aqueous solution. TBKi
(MRT68601, Fig. S1) was obtained from MRC Technology and
maintained as a frozen stock solution in DMSO. Bafilomycin A1
was obtained from Sigma and stored as a frozen stock solution in
DMSO. Pepstatin A was obtained from Sigma and stored as
a stock solution in ethanol. E64d was obtained from Calbiochem
and stored as a frozen stock solution in DMSO.
Antibodies
The antibodies used in this study are as follows: TBK1 (Rabbit
AOW9 monoclonal, Millipore), Phospho-Ser172–TBK1 (BD
Pharmingen), ATG5 (for ATG5-12, Rabbit polyclonal, Cell
Signalling Technology), ULK1 (Rabbit polyclonal A705, Cell
Signalling Technology), LC3B (Immunoblot, Rabbit monoclonal
D11, Cell Signalling Technology), LC3B (Immunofluorescence,
Mouse monoclonal 2G6, Nanotools), GABARAP (Rabbit poly-
clonal Ap1821a, Abgent), ERK (Rabbit polyclonal 9102, Cell
Signalling Technology), RelB (Rabbit monoclonal C1E4, Cell
Signalling Technology), Histone H3 (H3, Mouse monoclonal 6-6-
2, Millipore), Tax1bp1 (Rabbit poly HPA024432, Sigma HPA),
Ndp52 (Rabbit poly ab68588, Abcam), p62 (mouse 3/p62
monoclonal, BD Pharmingen), myc tag (Rat JAC6 monoclonal,
AbD Serotec [TBK1 coIP experiments] or Mouse 4A6 mono-
clonal, Millipore [GST pulldown experiments]), c-Rel (Rabbit
polyclonal, 4727,Cell Signalling Technology), RelA (Rabbit
monoclonal C22B4, Cell Signalling Technology), a-tubulin
(Mouse monoclonal DM1A, Sigma), HA (Rat monoclonal 3F10,
Roche), GST (GST-2 mouse monoclonal, Sigma), Optineurin
(Rabbit polyclonal Item no. 100000, Cayman Chemical), K-Ras
(Mouse monoclonal 3B10-2F2, Sigma). Anti-phospho-S403-p62
was a kind gift of Nobuyuki Nukina (RIKEN, Japan). Phospho-
specific antibodies to IRF3, RelA and JNK were obtained from
Cell Signalling Technology.
siRNA Transfection
In 35 mm dishes, 0.86105 A549 or 1.26105 NCI-H23 were
plated overnight. Cells were transfected for 8 h with Oligofecta-
mine (Invitrogen) and 10 nM siRNA (A549) or 20 nM siRNA
(NCI-H23), according to the manufacturer’s instructions. siRNA
duplexes were as follows: NTC (siGenome non-targeting control 1,
Dharmacon, sequence not provided by manufacturer), TBK1 si1
(Ambion, GGTTTGGCTCTTTAACCAT), TBK1 si2
(Hs_TBK1_6 Validated siRNA, Qiagen, sequence not provided
by manufacturer) ATG5 (siGenome duplex 004374-03, Dharma-
con, CATCTGAGCTACCCGGATA), ULK1 (Hs_ULK1_5 Val-
idated siRNA, Qiagen, sequence not provided by manufacturer),
TAX1BP1 (Hs_TAX1BP1_8 Validated siRNA, Qiagen,
CAGTCTTTGGCTTATCAAT), NDP52 (Hs_CALCOCO2_3
siRNA, Qiagen, TCAGGGACTTAGGTAATTT) and OPTN
(Hs_OPTN_2 siRNA, Qiagen, CAGCGGAATATTCCGATT-
CAT).
Tandem Fluorescent LC3B Assay
Cells stably expressing tandem fluorescent LC3B, from pBabe
puro tfLC3B, were treated as indicated in text and fixed and
mounted on glass slides. Multiple fields were imaged using wide-
field fluorescence microscopy, capturing images of both mCherry
fluorescence and GFP fluorescence with separated, optimised
exposures in separate channels. Visual inspection determined that
GFP positive puncta, virtually without exception, were also scored
as mCherry positive in corresponding images. The number of
mCherry positive puncta was counted across all cells and then the
number of GFP positive puncta was likewise summated. The total
number of ‘green+red’ autophagic structures were given by the
number of mCherry positive puncta, while ‘red’ late autophagic
structure numbers were derived by subtracting by GFP-positive
mCherry-negative puncta numbers. At least 100 cells were
counted for each condition.
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Lentiviral shRNA Infection and Assays
Virus was produced in 293FT cells using pCMV-VSVG and
pCMVRD8.2 plasmids according to established protocols [1].
Equivalent titres were used in control and experimental groups, in
the range of 5, M.O.I. ,10. 24 h post-infection, cells were
selected for 48 h in 2.5 mg/ml puromycin. For analysis beyond
72 h time point, cells were always replated into larger vessels, in
standard medium (no puromycin) to prevent attainment of
confluency in controls. Cell counting was performed by trypsinisa-
tion of live adherent cells and use of a haemocytometer. Numbers
were normalised so that the mean of independent experiments
would equal 1 for control treatments. Hairpins used were in
pLKO.1 puro, targeting sequences as follows: NTC (TAA GGC
TAT GAA GAG ATA C), GFP (ACA ACA GCC ACA ACG
TCT ATA), RELB (GGT GCA GAA AGA GGA CAT ATC),
ATG5-1 (ACT CAC ATA CAG TAG ATC ACT) ATG5-2 (GCT
AGC TGG CTG TCC ATA TTG) TBK1-1 (GCA GAA CGT
AGA TTA GCT TAT) TBK1-2 (GCG GCA GAG TTA GGT
GAA ATT), KRAS-1 (CCT CGT TTC TAC ACA GAG AAA),
KRAS-2 (GAG GGC TTT CTT TGT GTA TTT).
Protein Extraction and Immunoblotting
All cell extracts were made in RIPA buffer (50 mM Tris-HCl,
pH 7.5, 0.5% Na deoxycholate, 1% Triton-X-100, 150 mM
NaCl, complete protease inhibitors +1 mM EDTA (Roche),
2 mM Na orthovanadate 25 mM Na beta-glycerophosphate,
10 mM NaF, 10 mM Na pyrophosphate), with the exception of
lysates for LC3B or GABARAP immunoblotting, which were
extracted directly in 2X SDS-PAGE sample buffer (4% SDS, 20%
glycerol, 0.125 M Tris-HCl pH 7.5, 10% w/v beta-mercaptoetha-
nol, bromophenol blue). Gel electrophoresis was performed with
MOPS/Tris-Bis buffer system on gradient gels (Invitrogen).
Immunodetection techniques were performed according to
standard procedures using enhanced chemiluminescence detec-
tion. Nitrocellulose membrane for blotting was used in all
experiments except for LC3B and GABARAP immunodetection,
where PVDF was used.
Immunostaining and Microscopy
For immunofluorescence, cells were grown on glass coverslips
and fixed in 4% paraformaldehyde. Fluorescent protein fusions
were imaged on cells mounted at this point. Alternatively, if
further immunostaining was to be performed, cells were generally
permeabilised with 0.25% Triton-X-100. In cases where endog-
enous LC3B immunodetection was performed, permeabilisation
was for ten minutes at220uC with methanol. Cells were visualised
on an Olympus BX51 widefield fluorescence microscope with
constant acquisition time and illumination intensity across samples
sets, under 40 X magnification, using a DP71 digital capture
device, or using an Olympus FV1000 confocal microscope.
Quantification of puncta or nuclear RelB was always performed
by blind scoring. For merge images for colocalisation, adjustment
of relative level and curves for red or green channel was applied
across the whole image after acquisition using Paint.NET software.
For tandem fluorescent LC3B scoring, no adjustments were made.
GST Pull-down Assays
pDEST15-empty (GST only control), or pDEST15 expressing
GST fusions of ubiquitin-like proteins, were induced for 3 hours
with 0.1 mM IPTG in Rosetta 2 DE3 bacteria. After resuspension
of bacterial pellet in IP buffer (50 mM Tris-HCl, pH 7.5, 0.5%
IGEPAL CA-630, 150 mM NaCl, complete protease inhibitors
+1 mM EDTA [Roche]), cells were broken open by sonication,
and a soluble GST-positive fraction obtained by pelleting bacterial
debris. This fraction was used to pull-down mammalian control
lysates or lysates containing overexpressed myc-Tax1bp1. These
lysates were obtained from 293FT cells transfected for 48 h with
pcDNA 3.1 myc-His or pcDNA3.1 myc-Tax1bp1, respectively,
using Lipofectamine 2000 (Invitrogen) and 1 mg of DNA (in
35 mm dish), according to manufacturer’s instructions. Lysates
were made with IGEPAL IP buffer (below). Pull-down was
performed by coincubation overnight at 4uC and then purification
of complexes using Glutathione-Sepharose 4B and use of IGEPAL
IP buffer for washes.
Nuclear Fraction Enrichment
‘Quick’ fractionation was performed to minimise loss of nuclear
NF-kB. Briefly, cells were lysed in ice-cold cytosolic extraction
buffer (10 mM Hepes pH 7.9, 1.5 mM MgCl2, 10 mM KCl,
0.05% IGEPAL CA-630, 0.5 mM DTT, complete protease
inhibitors +1 mM EDTA (Roche), 2 mM Na orthovanadate,
25 mM Na beta-glycerophosphate, 10 mM NaF). A 3000 rpm
pellet was obtained from a spin in a benchtop microcentrifuge at
4uC. This pellet (nucleus and some membrane fragments) was
washed briefly with ice-cold extraction buffer and then immedi-
ately lysed in 2X SDS-PAGE sample buffer.
Immunoprecipitation
Briefly, cells were lysed in IGEPAL IP buffer (50 mM Tris-HCl,
pH 7.5, 0.5% IGEPAL CA-630, 150 mM NaCl, complete
protease inhibitors +1 mM EDTA (Roche), 2 mM Na orthova-
nadate 25 mM Na beta-glycerophosphate, 10 mM NaF, 10 mM
Na pyrophosphate), either directly or 48 h post-transfection with
indicated plasmids by Lipofectamine 2000 (Invitrogen) and 1 mg of
DNA (in 35 mm dish) according to manufacturer’s instructions.
Lysates were subject to immunoprecipitation for 4 hours using
1 mg of indicated antibody, for endogenous protein bait, pre-
bound to protein A/G agarose (Roche), or anti-myc magnetic
beads, for transfected protein bait (Cell Signalling Technology),
and three washes in lysis buffer. Protein was eluted from beads by
boiling in 2X SDS-PAGE sample buffer.
qRT-PCR
Two-step quantitative real-time PCR was performed on RNA
purified using Qiagen RNeasy kit and reverse transcribed using
first strand cDNA synthesis kit (Applied Biosystems). SYBR green
hot-start PCR kit (Finnzymes) was used for second reaction step on
a Corbett Rotor-Gene 3000 cycler. Primer sequences used for
qRT-PCR were as follows. 18S: GTAACCCGTTGAACCC-
CATT and CCATCCAATCGGTAGTAGCG BIRC3:
GCCCTCTAGTGTTCTAGTTAATCC and TACTCA-
CACCTTGGAAACCAC. All BIRC3 readings were normalised
to 18S.
Statistical Methods
All calculations of significance were done using one-tailed
Student’s t-test, or ANOVA with post-hoc analysis of significance
for greater than two experimental conditions, all using Microsoft
Excel with WinSTAT plugin.
Supporting Information
Figure S1 Characterisation of the TBK inhibitor
MRT68601. a) Chemical structure of MRT68601, the TBK
kinase inhibitory compound used in this study. b) Kinase
selectivity profile for the TBKi, MRT68601. Kinase selectivity
profiling was performed at the Protein Phosphorylation Unit,
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University of Dundee (James Hastie and Hilary McLauchlan) for
key kinases. TBKi is a potent inhibitor of both TBK1 and to
a lesser extent IKKe. With the exception of MARK3, the
compounds show at least 10-fold selectivity over TBK1 against all
of the other kinases tested. c,d) Inhibitory effects of TBKi
(MRT68601) on LPS-stimulated IRF3 phosphorylation and IFN-
b release in RAW264.7 macrophages. c) Cells were cultured in 6-
well plates (16106/well) and pre-incubated with 10-fold dilutions
of TBKi for 30 minutes, prior to stimulation with LPS (1 mg/ml)
for 1 hour and collection of lysates. Lysates were immunoblotted
with indicated phospho-specific antibodies to IRF3, RelA, JNK or
TBK1. d) Cells were cultured in 6-well plates (16106/well) and
pre-incubated with 10-fold dilutions of TBKi for 30 minutes, prior
to stimulation with LPS (1 mg/ml) for 2 hours and subsequent
nuclear fractionation and ELISA determination of DNA-bound
IRF3 (TransAMTM, Active Motif). Data presented as mean 6
S.D., n= 2 independent repeats.
(TIF)
Figure S2 Validation of Tax1bp1 and Ndp52 protein
complex formation with TBK1 and the location of
proposed LIR motifs in Tax1bp1. a) 293FT cells were
transfected with either pcDNA 3.1 myc-His or pcDNA 3.1 myc-
Tax1bp1 plasmid. 48 h later cells were lysed in IGEPAL IP buffer
and supernatants (input) immunoprecipitated with anti-myc
antibody and both input and immunoprecipitate samples blotted
with indicated antibodies. b) Exponentially growing A549 cells in
the basal state were lysed in IGEPAL IP buffer and subjected to
immunoprecipitation with either non-specific rabbit IgG or anti-
Ndp52 and both input and immunoprecipitate samples blotted
with indicated antibodies. Arrow indicates Ndp52, asterisk
indicates IgG heavy chain. c) Alignment of human Tax1bp1
and Ndp52 sequences showing potential canonical and non-
canonical LIR motifs in the N-terminal regions of Tax1bp1.
(TIF)
Figure S3 Basal localisation of c-Rel, RelA and RelB in
A549 cells. A549 cells growing exponentially, in the basal state,
were fixed and stained with indicated antibodies. Scale
bar = 50 mm.
(TIF)
Figure S4 Effect of lysosomal inhibitors on RelB nuclear
localisation. a-c) A549 cells were treated with a) DMSO or
0.1 mM Bafilomycin A1 (BafA1) for 48 h, b) PBS or 5 mM
chloroquine (CQ) for 24 h or c) DMSO/Ethanol (EtOH) vehicle
control or 10 mg/ml each E64d and Pepstatin A (PepA) for 48 h.
All cells were then stained and quantified for nuclear RelB (n= 3,
6 S.E.M., * = p,0.05, ** = p,0.01, #=not significant).
(TIF)
Figure S5 Requirement of autophagy, TBK1 and K-Ras
for proliferation and/or survival of A549 cells. a,b) A549
cells were infected with indicated lentiviral supernatants and a) cell
extracts blotted for indicated proteins at 96 hours post infection or
b) cell numbers counted at 120 h (n= 3, 6 S.E.M.). c,d) A549
cells were treated with indicated concentrations of MRT68601
(TBKi) for 72 hours and c) images taken by phase contrast
microscopy or d) viable cells counted (n= 3, 6 S.E.M.). e,f) A549
cells were infected with indicated lentiviral supernatants and e) cell
extracts blotted for indicated proteins at 72 hours post infection or
f) cell numbers counted at 120 h (n = 3, 6 S.E.M.).
(TIF)
Figure S6 p62 phosphorylation downstream of TBK1
activity. A549 cells were treated overnight with 10 mM TBKi
and stained with anti-phospho-Ser403-p62 antibody. Scale
bar = 50 mm.
(TIF)
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